Cilostazol
- Product NDC
- 70436-050
- 11-digit product format
- 704360050
- Labeler code
- 70436
- Product ID
- 70436-050_bc0bee31-2790-4002-be33-09bce2d0216c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cilostazol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Slate Run Pharmaceuticals, LLC
- Application
- ANDA077208
- Marketing category
- ANDA
- Marketing start
- 2018-01-01
- Marketing end
- 0000-00-00
- Substance
- CILOSTAZOL
- Active strength
- 50 mg/1
- Pharmacologic classes
- Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70436-050-06 | 70436005006 | 60 TABLET in 1 BOTTLE (70436-050-06) | 60 tablet | 2018-01-01 | 0000-00-00 | No | No | Current |